市場調査レポート

商品コード

1552515

多血小板血漿市場、規模、シェア、動向、産業分析レポート：タイプ別、用途別、最終用途別、地域別- 市場予測、2024年～2032年

Platelet Rich Plasma Market Size, Share, Trends, Industry Analysis Report: By Type, By Application, By End-Use, and By Region - Market Forecast, 2024 - 2032

出版日: 2024年08月01日
発行: Polaris Market Research
ページ情報: 英文 116 Pages
納期: 即日から翌営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,250 612,255円

レポートPDFを1名のみがご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 5,250 756,315円

レポートPDFを20名様までご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 6,250 900,375円

レポートPDFを同一企業の全世界の方にご利用頂けるライセンスです。ご利用人数に制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Polaris Market Research社の最新調査によると、世界の多血小板血漿市場規模は2032年までに27億8,389万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

多血小板血漿の需要は、世界の様々な医療＆美容分野で力強い成長を遂げています。PRPは、腱炎、関節炎、スポーツ関連傷害などの筋骨格系の傷害を含む幅広い症状の治療に汎用性があり、その人気に大きく寄与しています。整形外科では、治癒を早め、手術後の回復時間を短縮するためにPRPが使用されることが増えており、非侵襲的な治療法を求めるアスリートや高齢者の両方にアピールしています。

多血小板血漿（PRP）の用途は、皮膚の若返り、毛髪の回復、創傷治癒のための皮膚科にも広がっており、外科手術以外の美容強化に対する消費者の関心がその原動力となっています。また、変形性関節症などの慢性疾患の増加や、低侵襲治療を好む高齢化もPRPの採用をさらに後押ししています。PRP調製法における技術の進歩と、その有効性を裏付ける臨床的証拠が、引き続き市場の拡大を後押ししています。

PRPが主流の医療行為に統合され、その治療効果を肯定する臨床研究が増加していることが、市場の持続的成長に寄与しています。認知度が高まり、ヘルスケアプロバイダーがPRPの可能性を受け入れるにつれて、市場は世界的に上昇基調を続けるものと思われます。

PRP市場レポートハイライト

純粋多血小板血漿（P-PRP）は、血小板濃度が高く、慢性疾患の治療や組織の修復・再生促進に有効であることから、2023年の市場を独占しました。

一般外科カテゴリーは、術後の回復を促進し合併症を減少させるPRPの役割により、最も高いCAGRを記録すると推定され、それにより外科ヘルスケアの将来が形成されます。

北米は2023年に世界のPRP市場を独占し、美容外科手術、整形外科手術、スポーツ傷害からの需要に牽引され、関節炎症例と広範な用途によって強化されました。

多血小板血漿（PRP）-業界の概要
バリューチェーン分析
- 多血小板血漿（PRP）市場力学
- 促進要因と機会
  - 美容外科や皮膚科におけるPRPの需要増加
  - 高齢者人口の増加、整形外科およびスポーツ傷害の発生率の増加により、予測期間中にPRPの需要が加速します。
- 抑制要因と課題
  - PRP療法の高額な費用と償還ポリシーの欠如が市場の成長を妨げる可能性がある
ポーターの5つの力
- 代替品の脅威：（低～中）
- 新規参入業者の脅威：（中～高）
- 買い手の交渉力：（低～中）
- 供給企業の交渉力：（中～高）
- 競争企業間の敵対関係：（中から高）
PESTLE分析
COVID-19の影響分析と業界動向

第5章多血小板血漿（PRP）市場：タイプ別

イントロダクション
純粋血小板多血漿（P-PRP）
白血球および血小板含有血漿（L-PRP）
純粋血小板フィブリン（P-PRF）
白血球および血小板に富むフィブリン（L-PRF）

第6章多血小板血漿（PRP）市場：用途別

イントロダクション
整形外科
スポーツ医学
一般外科
皮膚科
眼科
神経学
心臓病学
その他

第7章多血小板血漿（PRP）市場：最終用途別

イントロダクション
病院
クリニック
その他

第8章多血小板血漿（PRP）市場：地域別

イントロダクション
北米
- 北米：タイプ別
- 北米：用途別
- 北米：最終用途別
- 米国
- カナダ
欧州
- 欧州：タイプ別
- 欧州：用途別
- 欧州：最終用途別
- フランス
- ドイツ
- 英国
- イタリア
- オランダ
- スペイン
- ロシア
- その他欧州
アジア太平洋
- アジア太平洋：タイプ別
- アジア太平洋：用途別
- アジア太平洋：最終用途別
- 日本
- 中国
- インド
- マレーシア
- インドネシア
- 韓国
- オーストラリア
- アジア太平洋地域のその他諸国
ラテンアメリカ
- ラテンアメリカ：タイプ別
- ラテンアメリカ：用途別
- ラテンアメリカ：最終用途別
- メキシコ
- ブラジル
- アルゼンチン
- その他ラテンアメリカ
中東アフリカ
- 中東・アフリカ：種類別
- 中東・アフリカ：用途別
- 中東・アフリカ：最終用途別
- サウジアラビア
- 南アフリカ
- 中東・アフリカの残り

第9章競合情勢

主要市場企業：分類
戦略的枠組み
ベンダー情勢
戦略の分類
- 発売/承認/開発

第10章企業プロファイル

Vivostat
Arthrex, Inc.
RegenOrthoSport
Dr PRP USA LLC
Juventix Regenerative Medical, LLC.
Terumo Cardiovascular Systems Corporation
Zimmer Biomet
Isto Biologics
APEX Biologix
Regen Lab SA

図表

List of Tables

Table 1 Platelet Rich Plasma (PRP) Market, By Type, 2019 - 2032 (USD Million)
Table 2 Platelet Rich Plasma (PRP) Market, By Pure Platelet-Rich Plasma (P-PRP), 2019 - 2032 (USD Million)
Table 3 Platelet Rich Plasma (PRP) Market, By Leukocyte-and Platelet-Rich Plasma (L-PRP), 2019 - 2032 (USD Million)
Table 4 Platelet Rich Plasma (PRP) Market, By Pure Platelet-Rich Fibrin (P-PRF), 2019 - 2032 (USD Million)
Table 5 Platelet Rich Plasma (PRP) Market, By Leukocyte- and Platelet-Rich Fibrin (L-PRF), 2019 - 2032 (USD Million)
Table 6 Platelet Rich Plasma (PRP) Market, By Application, 2019 - 2032 (USD Million)
Table 7 Platelet Rich Plasma (PRP) Market, By Orthopedics, 2019 - 2032 (USD Million)
Table 8 Platelet Rich Plasma (PRP) Market, By Sports Medicine, 2019 - 2032 (USD Million)
Table 9 Platelet Rich Plasma (PRP) Market, By General Surgery, 2019 - 2032 (USD Million)
Table 10 Platelet Rich Plasma (PRP) Market, By Dermatology, 2019 - 2032 (USD Million)
Table 11 Platelet Rich Plasma (PRP) Market, By Ophthalmology, 2019 - 2032 (USD Million)
Table 12 Platelet Rich Plasma (PRP) Market, By Ophthalmology, 2019 - 2032 (USD Million)
Table 13 Platelet Rich Plasma (PRP) Market, By Cardiology, 2019 - 2032 (USD Million)
Table 14 Platelet Rich Plasma (PRP) Market, By Others, 2019 - 2032 (USD Million)
Table 15 Platelet Rich Plasma (PRP) Market, By End-Use, 2019 - 2032 (USD Million)
Table 16 Platelet Rich Plasma (PRP) Market, By Hospitals, 2019 - 2032 (USD Million)
Table 17 Platelet Rich Plasma (PRP) Market, By Clinics, 2019 - 2032 (USD Million)
Table 18 Platelet Rich Plasma (PRP) Market, By Others, 2019 - 2032 (USD Million)
Table 19 Platelet Rich Plasma (PRP) Market Assessment, By Geography, 2019 - 2032 (USD Million)
Table 20 North America Platelet Rich Plasma (PRP) Market, By Type, 2019 - 2032 (USD Million)
Table 21 North America Platelet Rich Plasma (PRP) Market, By Application, 2019 - 2032 (USD Million)
Table 22 North America Platelet Rich Plasma (PRP) Market, By End-Use, 2019 - 2032 (USD Million)
Table 23 U.S. Platelet Rich Plasma (PRP) Market, By Type, 2019 - 2032 (USD Million)
Table 24 U.S. Platelet Rich Plasma (PRP) Market, By Application, 2019 - 2032 (USD Million)
Table 25 U.S. Platelet Rich Plasma (PRP) Market, By End-Use, 2019 - 2032 (USD Million)
Table 26 Canada Platelet Rich Plasma (PRP) Market, By Type, 2019 - 2032 (USD Million)
Table 27 Canada Platelet Rich Plasma (PRP) Market, By Application, 2019 - 2032 (USD Million)
Table 28 Canada Platelet Rich Plasma (PRP) Market, By End-Use, 2019 - 2032 (USD Million)
Table 29 Europe Platelet Rich Plasma (PRP) Market, By Type, 2019 - 2032 (USD Million)
Table 30 Europe Platelet Rich Plasma (PRP) Market, By Application, 2019 - 2032 (USD Million)
Table 31 Europe Platelet Rich Plasma (PRP) Market, By End-Use, 2019 - 2032 (USD Million)
Table 32 France Platelet Rich Plasma (PRP) Market, By Type, 2019 - 2032 (USD Million)
Table 33 France Platelet Rich Plasma (PRP) Market, By Application, 2019 - 2032 (USD Million)
Table 34 France Platelet Rich Plasma (PRP) Market, By End-Use, 2019 - 2032 (USD Million)
Table 35 Germany Platelet Rich Plasma (PRP) Market, By Type, 2019 - 2032 (USD Million)
Table 36 Germany Platelet Rich Plasma (PRP) Market, By Application, 2019 - 2032 (USD Million)
Table 37 Germany Platelet Rich Plasma (PRP) Market, By End-Use, 2019 - 2032 (USD Million)
Table 38 UK Platelet Rich Plasma (PRP) Market, By Type, 2019 - 2032 (USD Million)
Table 39 UK Platelet Rich Plasma (PRP) Market, By Application, 2019 - 2032 (USD Million)
Table 40 UK Platelet Rich Plasma (PRP) Market, By End-Use, 2019 - 2032 (USD Million)
Table 41 Italy Platelet Rich Plasma (PRP) Market, By Type, 2019 - 2032 (USD Million)
Table 42 Italy Platelet Rich Plasma (PRP) Market, By Application, 2019 - 2032 (USD Million)
Table 43 Italy Platelet Rich Plasma (PRP) Market, By End-Use, 2019 - 2032 (USD Million)
Table 44 Netherlands Platelet Rich Plasma (PRP) Market, By Type, 2019 - 2032 (USD Million)
Table 45 Netherlands Platelet Rich Plasma (PRP) Market, By Application, 2019 - 2032 (USD Million)
Table 46 Netherlands Platelet Rich Plasma (PRP) Market, By End-Use, 2019 - 2032 (USD Million)
Table 47 Spain Platelet Rich Plasma (PRP) Market, By Type, 2019 - 2032 (USD Million)
Table 48 Spain Platelet Rich Plasma (PRP) Market, By Application, 2019 - 2032 (USD Million)
Table 49 Spain Platelet Rich Plasma (PRP) Market, By End-Use, 2019 - 2032 (USD Million)
Table 50 Russia Platelet Rich Plasma (PRP) Market, By Type, 2019 - 2032 (USD Million)
Table 51 Russia Platelet Rich Plasma (PRP) Market, By Application, 2019 - 2032 (USD Million)
Table 52 Russia Platelet Rich Plasma (PRP) Market, By End-Use, 2019 - 2032 (USD Million)
Table 53 Rest of Europe Platelet Rich Plasma (PRP) Market, By Type, 2019 - 2032 (USD Million)
Table 54 Rest of Europe Platelet Rich Plasma (PRP) Market, By Application, 2019 - 2032 (USD Million)
Table 55 Rest of Europe Platelet Rich Plasma (PRP) Market, By End-Use, 2019 - 2032 (USD Million)
Table 56 Asia Pacific Platelet Rich Plasma (PRP) Market, By Type, 2019 - 2032 (USD Million)
Table 57 Asia Pacific Platelet Rich Plasma (PRP) Market, By Application, 2019 - 2032 (USD Million)
Table 58 Asia Pacific Platelet Rich Plasma (PRP) Market, By End-Use, 2019 - 2032 (USD Million)
Table 59 Japan Platelet Rich Plasma (PRP) Market, By Type, 2019 - 2032 (USD Million)
Table 60 Japan Platelet Rich Plasma (PRP) Market, By Application, 2019 - 2032 (USD Million)
Table 61 Japan Platelet Rich Plasma (PRP) Market, By End-Use, 2019 - 2032 (USD Million)
Table 62 China Platelet Rich Plasma (PRP) Market, By Type, 2019 - 2032 (USD Million)
Table 63 China Platelet Rich Plasma (PRP) Market, By Application, 2019 - 2032 (USD Million)
Table 64 China Platelet Rich Plasma (PRP) Market, By End-Use, 2019 - 2032 (USD Million)
Table 65 India Platelet Rich Plasma (PRP) Market, By Type, 2019 - 2032 (USD Million)
Table 66 India Platelet Rich Plasma (PRP) Market, By Application, 2019 - 2032 (USD Million)
Table 67 India Platelet Rich Plasma (PRP) Market, By End-Use, 2019 - 2032 (USD Million)
Table 68 Malaysia Platelet Rich Plasma (PRP) Market, By Type, 2019 - 2032 (USD Million)
Table 69 Malaysia Platelet Rich Plasma (PRP) Market, By Application, 2019 - 2032 (USD Million)
Table 70 Malaysia Platelet Rich Plasma (PRP) Market, By End-Use, 2019 - 2032 (USD Million)
Table 71 Indonesia Platelet Rich Plasma (PRP) Market, By Type, 2019 - 2032 (USD Million)
Table 72 Indonesia Platelet Rich Plasma (PRP) Market, By Application, 2019 - 2032 (USD Million)
Table 73 Indonesia Platelet Rich Plasma (PRP) Market, By End-Use, 2019 - 2032 (USD Million)
Table 74 South Korea Platelet Rich Plasma (PRP) Market, By Type, 2019 - 2032 (USD Million)
Table 75 South Korea Platelet Rich Plasma (PRP) Market, By Application, 2019 - 2032 (USD Million)
Table 76 South Korea Platelet Rich Plasma (PRP) Market, By End-Use, 2019 - 2032 (USD Million)
Table 77 Australia Platelet Rich Plasma (PRP) Market, By Type, 2019 - 2032 (USD Million)
Table 78 Australia Platelet Rich Plasma (PRP) Market, By Application, 2019 - 2032 (USD Million)
Table 79 Australia Platelet Rich Plasma (PRP) Market, By End-Use, 2019 - 2032 (USD Million)
Table 80 Rest of APAC Platelet Rich Plasma (PRP) Market, By Type, 2019 - 2032 (USD Million)
Table 81 Rest of APAC Platelet Rich Plasma (PRP) Market, By Application, 2019 - 2032 (USD Million)
Table 82 Rest of APAC Platelet Rich Plasma (PRP) Market, By End-Use, 2019 - 2032 (USD Million)
Table 83 Latin America Platelet Rich Plasma (PRP) Market, By Type, 2019 - 2032 (USD Million)
Table 84 Latin America Platelet Rich Plasma (PRP) Market, By Application, 2019 - 2032 (USD Million)
Table 85 Latin America Platelet Rich Plasma (PRP) Market, By End-Use, 2019 - 2032 (USD Million)
Table 86 Mexico Platelet Rich Plasma (PRP) Market, By Type, 2019 - 2032 (USD Million)
Table 87 Mexico Platelet Rich Plasma (PRP) Market, By Application, 2019 - 2032 (USD Million)
Table 88 Mexico Platelet Rich Plasma (PRP) Market, By End-Use, 2019 - 2032 (USD Million)
Table 89 Brazil Platelet Rich Plasma (PRP) Market, By Type, 2019 - 2032 (USD Million)
Table 90 Brazil Platelet Rich Plasma (PRP) Market, By Application, 2019 - 2032 (USD Million)
Table 91 Brazil Platelet Rich Plasma (PRP) Market, By End-Use, 2019 - 2032 (USD Million)
Table 92 Argentina Platelet Rich Plasma (PRP) Market, By Type, 2019 - 2032 (USD Million)
Table 93 Argentina Platelet Rich Plasma (PRP) Market, By Application, 2019 - 2032 (USD Million)
Table 94 Argentina Platelet Rich Plasma (PRP) Market, By End-Use, 2019 - 2032 (USD Million)
Table 95 Rest of LATAM Platelet Rich Plasma (PRP) Market, By Type, 2019 - 2032 (USD Million)
Table 96 Rest of LATAM Platelet Rich Plasma (PRP) Market, By Application, 2019 - 2032 (USD Million)
Table 97 Rest of LATAM Platelet Rich Plasma (PRP) Market, By End-Use, 2019 - 2032 (USD Million)
Table 98 Middle East & Africa Platelet Rich Plasma (PRP) Market, By Type, 2019 - 2032 (USD Million)
Table 99 Middle East & Africa Platelet Rich Plasma (PRP) Market, By Application, 2019 - 2032 (USD Million)
Table 100 Middle East & Africa Platelet Rich Plasma (PRP) Market, By End-Use, 2019 - 2032 (USD Million)
Table 101 Saudi Arabia Platelet Rich Plasma (PRP) Market, By Type, 2019 - 2032 (USD Million)
Table 102 Saudi Arabia Platelet Rich Plasma (PRP) Market, By Application, 2019 - 2032 (USD Million)
Table 103 Saudi Arabia Platelet Rich Plasma (PRP) Market, By End-Use, 2019 - 2032 (USD Million)
Table 104 South Africa Platelet Rich Plasma (PRP) Market, By Type, 2019 - 2032 (USD Million)
Table 105 South Africa Platelet Rich Plasma (PRP) Market, By Application, 2019 - 2032 (USD Million)
Table 106 South Africa Platelet Rich Plasma (PRP) Market, By End-Use, 2019 - 2032 (USD Million)
Table 107 Rest of MEA Platelet Rich Plasma (PRP) Market, By Type, 2019 - 2032 (USD Million)
Table 108 Rest of MEA Platelet Rich Plasma (PRP) Market, By Application, 2019 - 2032 (USD Million)
Table 109 Rest of MEA Platelet Rich Plasma (PRP) Market, By End-Use, 2019 - 2032 (USD Million)

List of Figures

Figure 1. Information Procurement
Figure 2. Primary Research Pattern
Figure 3. Primary research process
Figure 4. Market research approaches - Bottom-Up Approach
Figure 5. Market research approaches - Top-Down Approach
Figure 6. Market research approaches - Combined Approach
Figure 7. Executive Summary
Figure 8. Market by Region, 2022 (USD Million)
Figure 9. Platelet Rich Plasma (PRP) Market, 2019 - 2032 (USD Million)
Figure 10. Value Chain Analysis
Figure 11. Porter's Five Forces
Figure 12. PESTLE Analysis
Figure 13. Market by Type
Figure 14. Platelet Rich Plasma (PRP) Market, By Type, 2022 & 2032 (USD Million)
Figure 15. Market by Application
Figure 16. Platelet Rich Plasma (PRP) Market, By Application, 2022 & 2032 (USD Million)
Figure 17. Market by End-Use
Figure 18. Platelet Rich Plasma (PRP) Market, By End-Use, 2022 & 2032 (USD Million)
Figure 19. Platelet Rich Plasma (PRP) Market Assessment, By Geography, 2022 & 2032 (USD Million)

Product Code: PM5030

The global platelet rich plasma market size is expected to reach USD 2,783.89 million by 2032, according to a new study by Polaris Market Research. The report "Global Platelet Rich Plasma (PRP) Market Size, Share, Trends, Industry Analysis Report: By Type, By Application, By End-Use (Hospitals, Clinics, and Others), and By Region (North America, Europe, Asia-Pacific, Middle East & Africa, And Latin America) - Market Forecast, 2024 - 2032." gives a detailed insight into current market dynamics and provides analysis on future market growth.

The demand for platelet-rich plasma is experiencing robust growth across various medical and aesthetic fields globally. PRP's versatility in treating a wide range of conditions, including musculoskeletal injuries like tendonitis, arthritis, and sports-related injuries, has significantly contributed to its popularity. In orthopedics, PRP is increasingly used to expedite healing and reduce recovery times post-surgery, appealing to both athletes and aging populations alike seeking non-invasive treatment options.

PRP's applications extend into dermatology for skin rejuvenation, hair restoration, and wound healing, driven by consumer interest in non-surgical cosmetic enhancements. Also, the rise in chronic conditions such as osteoarthritis and the aging population's preference for minimally invasive treatments further boost PRP's adoption. Technological advancements in PRP preparation methods and clinical evidence supporting its efficacy continue to boost market expansion.

The integration of PRP into mainstream medical practices and the growing number of clinical studies affirming its therapeutic benefits contribute to sustained market growth. As awareness increases and healthcare providers embrace PRP's potential, the market is poised to continue its upward trajectory globally.

PRP Market Report Highlights

Pure platelet-rich plasma (P-PRP) dominated the market in 2023 due to its high platelet concentration and effectiveness in treating chronic conditions and promoting tissue repair and regeneration.

The general surgery category is estimated to register a highest CAGR, driven by PRP's role in enhancing postoperative recovery and reducing complications, thereby shaping the future of surgical healthcare.

North America dominated the global PRP market in 2023, driven by demand from cosmetic surgeries, orthopedic procedures, and sports injuries, strengthened by arthritis cases and extensive applications.

The global key market players include Vivostat, Arthrex Inc., RegenOrthoSport, Dr. PRP USA LLC, Juventix Regenerative Medical, LLC, Terumo Cardiovascular Systems Corporation, Zimmer Biomet, Isto Biologics, Apex Biologix, and Regen Lab SA.

Polaris Market Research has segmented the platelet rich plasma market report based on type, application, end-use, and region:

PRP Market - Type Outlook (Revenue - USD million, 2019 - 2032)

Pure Platelet-Rich Plasma (P-PRP)
Leukocyte-and Platelet-Rich Plasma (L-PRP)
Pure Platelet-Rich Fibrin (P-PRF) - or Leukocyte-Poor Platelet-Rich Fibrin
Leukocyte- and Platelet-Rich Fibrin (L-PRF)

Platelet Rich Plasma Market - Application Outlook (Revenue - USD million, 2019 - 2032)

Orthopedics
Sports Medicine
General Surgery
Dermatology
Ophthalmology
Neurology
Cardiology
Others

Platelet Rich Plasma Market - End-Use (Revenue - USD million, 2019 - 2032)

Hospitals
Clinics
Others

Platelet Rich Plasma Market - Regional Outlook (Revenue - USD million, 2019 - 2032)

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Australia
Malaysia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa

1. Introduction

1.1 Report Description
- 1.1.1 Objective of the Study
- 1.1.2 Market Scope
- 1.1.3 Assumptions
1.2 Stakeholders

2. Research Methodology

2.1 Research Methodology
2.2 Research Scope and Assumptions
2.3 Information Procurement
- 2.3.1 Purchased Database
- 2.3.2 Internal Database
- 2.3.3 Secondary Sources
- 2.3.4 Third Party Perspective
- 2.3.5 Primary Research
2.4 Information Analysis
- 2.4.1 Data Analysis Models
2.5 Market Formulation and Data Visualization
2.6 Data Validation and Publishing (Secondary Sources)

3. Executive Summary

4. Market Insights

4.1 Platelet Rich Plasma (PRP) - Industry snapshot
4.2 Platelet Rich Plasma (PRP) Market - Value Chain Analysis
- 4.2.1 Platelet Rich Plasma (PRP) Market Dynamics
- 4.2.2 Drivers and Opportunities
  - 4.2.2.1 Rise in demand of PRP in cosmetic surgeries and dermatology
  - 4.2.2.2 Increasing geriatric population, and rise in the occurrence of orthopaedic and sports injuries accelerate the PRP demand over the forecast period
- 4.2.3 Restraints and Challenges
  - 4.2.3.1 High cost of PRP therapy and lack of reimbursement policy may hamper the market growth
4.3 Platelet Rich Plasma (PRP) Market - Porter's Five Forces
- 4.3.1 Threat of Substitutes: (Low to Moderate)
- 4.3.2 Threat of New Entrants: (Moderate to high)
- 4.3.3 Bargaining power of buyers: (Low to Moderate)
- 4.3.4 Bargaining power of suppliers: (Moderate to High)
- 4.3.5 Competitive Rivalry: (Moderate to High)
4.4 Platelet Rich Plasma (PRP) Market - PESTLE Analysis
4.5 Covid-19 Impact Analysis & Industry Trends

5. Platelet Rich Plasma (PRP) Market Assessment by Type

5.1 Introduction
5.2 Pure Platelet-Rich Plasma (P-PRP)
5.3 Leukocyte-and Platelet-Rich Plasma (L-PRP)
5.4 Pure Platelet-Rich Fibrin (P-PRF)
5.5 Leukocyte- and Platelet-Rich Fibrin (L-PRF)

6. Platelet Rich Plasma (PRP) Market Assessment by Application

6.1 Introduction
6.2 Orthopedics
6.3 Sports Medicine
6.4 General Surgery
6.5 Dermatology
6.6 Ophthalmology
6.7 Neurology
6.8 Cardiology
6.9 Others

7. Platelet Rich Plasma (PRP) Market Assessment by End-Use

7.1 Introduction
7.2 Hospitals
7.3 Clinics
7.4 Others

8. Platelet Rich Plasma (PRP) Market Assessment by Region

8.1 Introduction
8.2 Platelet Rich Plasma (PRP) Market - North America
- 8.2.1 North America Blood Plasma, By Type
- 8.2.2 North America Blood Plasma, By Application
- 8.2.3 North America Platelet Rich Plasma (PRP) Market, By End-Use
- 8.2.4 Platelet Rich Plasma (PRP) Market - U.S.
  - 8.2.4.1 U.S. Blood Plasma, By Type
  - 8.2.4.2 U.S. Blood Plasma, By Application
  - 8.2.4.3 U.S. Blood Plasma, By End-Use
- 8.2.5 Platelet Rich Plasma (PRP) Market - Canada
  - 8.2.5.1 Canada Blood Plasma, By Type
  - 8.2.5.2 Canada Blood Plasma, By Application
  - 8.2.5.3 Canada Blood Plasma, By End-Use
8.3 Platelet Rich Plasma (PRP) Market - Europe
- 8.3.1 Europe Blood Plasma, By Type
- 8.3.2 Europe Blood Plasma, By Application
- 8.3.3 Europe Platelet Rich Plasma (PRP) Market, By End-Use
- 8.3.4 Platelet Rich Plasma (PRP) Market - France
  - 8.3.4.1 France Blood Plasma, By Type
  - 8.3.4.2 France Blood Plasma, By Application
  - 8.3.4.3 France Blood Plasma, By End-Use
- 8.3.5 Platelet Rich Plasma (PRP) Market - Germany
  - 8.3.5.1 Germany Blood Plasma, By Type
  - 8.3.5.2 Germany Blood Plasma, By Application
  - 8.3.5.3 Germany Blood Plasma, By End-Use
- 8.3.6 Platelet Rich Plasma (PRP) Market - UK
  - 8.3.6.1 UK Blood Plasma, By Type
  - 8.3.6.2 UK Blood Plasma, By Application
  - 8.3.6.3 UK Blood Plasma, By End-Use
- 8.3.7 Platelet Rich Plasma (PRP) Market - Italy
  - 8.3.7.1 Italy Blood Plasma, By Type
  - 8.3.7.2 Italy Blood Plasma, By Application
  - 8.3.7.3 Italy Blood Plasma, By End-Use
- 8.3.8 Platelet Rich Plasma (PRP) Market - Netherlands
  - 8.3.8.1 Netherlands Blood Plasma, By Type
  - 8.3.8.2 Netherlands Blood Plasma, By Application
  - 8.3.8.3 Netherlands Blood Plasma, By End-Use
- 8.3.9 Platelet Rich Plasma (PRP) Market - Spain
  - 8.3.9.1 Spain Blood Plasma, By Type
  - 8.3.9.2 Spain Blood Plasma, By Application
  - 8.3.9.3 Spain Blood Plasma, By End-Use
- 8.3.10 Platelet Rich Plasma (PRP) Market - Russia
  - 8.3.10.1 Russia Blood Plasma, By Type
  - 8.3.10.2 Russia Blood Plasma, By Application
  - 8.3.10.3 Russia Blood Plasma, By End-Use
- 8.3.11 Platelet Rich Plasma (PRP) Market - Rest of Europe
  - 8.3.11.1 Rest of Europe Blood Plasma, By Type
  - 8.3.11.2 Rest of Europe Blood Plasma, By Application
  - 8.3.11.3 Rest of Europe Blood Plasma, By End-Use
8.4 Platelet Rich Plasma (PRP) Market - Asia Pacific
- 8.4.1 Asia Pacific Blood Plasma, By Type
- 8.4.2 Asia Pacific Blood Plasma, By Application
- 8.4.3 Asia Pacific Platelet Rich Plasma (PRP) Market, By End-Use
- 8.4.4 Platelet Rich Plasma (PRP) Market - Japan
  - 8.4.4.1 Japan Blood Plasma, By Type
  - 8.4.4.2 Japan Blood Plasma, By Application
  - 8.4.4.3 Japan Blood Plasma, By End-Use
- 8.4.5 Platelet Rich Plasma (PRP) Market - China
  - 8.4.5.1 China Blood Plasma, By Type
  - 8.4.5.2 China Blood Plasma, By Application
  - 8.4.5.3 China Blood Plasma, By End-Use
- 8.4.6 Platelet Rich Plasma (PRP) Market - India
  - 8.4.6.1 India Blood Plasma, By Type
  - 8.4.6.2 India Blood Plasma, By Application
  - 8.4.6.3 India Blood Plasma, By End-Use
- 8.4.7 Platelet Rich Plasma (PRP) Market - Malaysia
  - 8.4.7.1 Malaysia Blood Plasma, By Type
  - 8.4.7.2 Malaysia Blood Plasma, By Application
  - 8.4.7.3 Malaysia Blood Plasma, By End-Use
- 8.4.8 Platelet Rich Plasma (PRP) Market - Indonesia
  - 8.4.8.1 Indonesia Blood Plasma, By Type
  - 8.4.8.2 Indonesia Blood Plasma, By Application
  - 8.4.8.3 Indonesia Blood Plasma, By End-Use
- 8.4.9 Platelet Rich Plasma (PRP) Market - South Korea
  - 8.4.9.1 South Korea Blood Plasma, By Type
  - 8.4.9.2 South Korea Blood Plasma, By Application
  - 8.4.9.3 South Korea Blood Plasma, By End-Use
- 8.4.10 Platelet Rich Plasma (PRP) Market - Australia
  - 8.4.10.1 Australia Blood Plasma, By Type
  - 8.4.10.2 Australia Blood Plasma, By Application
  - 8.4.10.3 Australia Blood Plasma, By End-Use
- 8.4.11 Platelet Rich Plasma (PRP) Market - Rest of APAC
  - 8.4.11.1 Rest of APAC Blood Plasma, By Type
  - 8.4.11.2 Rest of APAC Blood Plasma, By Application
  - 8.4.11.3 Rest of APAC Blood Plasma, By End-Use
8.5 Platelet Rich Plasma (PRP) Market - Latin America
- 8.5.1 Latin America Blood Plasma, By Type
- 8.5.2 Latin America Blood Plasma, By Application
- 8.5.3 Latin America Platelet Rich Plasma (PRP) Market, By End-Use
- 8.5.4 Platelet Rich Plasma (PRP) Market - Mexico
  - 8.5.4.1 Mexico Blood Plasma, By Type
  - 8.5.4.2 Mexico Blood Plasma, By Application
  - 8.5.4.3 Mexico Blood Plasma, By End-Use
- 8.5.5 Platelet Rich Plasma (PRP) Market - Brazil
  - 8.5.5.1 Brazil Blood Plasma, By Type
  - 8.5.5.2 Brazil Blood Plasma, By Application
  - 8.5.5.3 Brazil Blood Plasma, By End-Use
- 8.5.6 Platelet Rich Plasma (PRP) Market - Argentina
  - 8.5.6.1 Argentina Blood Plasma, By Type
  - 8.5.6.2 Argentina Blood Plasma, By Application
  - 8.5.6.3 Argentina Blood Plasma, By End-Use
- 8.5.7 Platelet Rich Plasma (PRP) Market - Rest of Latin America
  - 8.5.7.1 Rest of LATAM Blood Plasma, By Type
  - 8.5.7.2 Rest of LATAM Blood Plasma, By Application
  - 8.5.7.3 Rest of LATAM Blood Plasma, By End-Use
8.6 Platelet Rich Plasma (PRP) Market - Middle East Africa
- 8.6.1 Middle East & Africa Blood Plasma, By Type
- 8.6.2 Middle East & Africa Blood Plasma, By Application
- 8.6.3 Middle East & Africa Platelet Rich Plasma (PRP) Market, By End-Use
- 8.6.4 Platelet Rich Plasma (PRP) Market - Saudi Arabia
  - 8.6.4.1 Saudi Arabia Blood Plasma, By Type
  - 8.6.4.2 Saudi Arabia Blood Plasma, By Application
  - 8.6.4.3 Saudi Arabia Blood Plasma, By End-Use
- 8.6.5 Platelet Rich Plasma (PRP) Market - South Africa
  - 8.6.5.1 South Africa Blood Plasma, By Type
  - 8.6.5.2 South Africa Blood Plasma, By Application
  - 8.6.5.3 South Africa Blood Plasma, By End-Use
- 8.6.6 Platelet Rich Plasma (PRP) Market - Rest of MEA
  - 8.6.6.1 Rest of MEA Blood Plasma, By Type
  - 8.6.6.2 Rest of MEA Blood Plasma, By Application
  - 8.6.6.3 Rest of MEA Blood Plasma, By End-Use

9. Competitive Landscape

9.1 Key Market Players: Categorization
9.2 Strategy Framework
9.3 Vendor Landscape
9.4 Strategies Categorization
- 9.4.1 Launch/Approval/Development

10. Company Profiles

10.1 Vivostat
- 10.1.1 Business Overview
- 10.1.2 Products and Services
10.2 Arthrex, Inc.
- 10.2.1 Business Overview
- 10.2.2 Products and Services
- 10.2.3 Recent Developments
10.3 RegenOrthoSport
- 10.3.1 Business Overview
- 10.3.2 Products and Services
10.4 Dr PRP USA LLC
- 10.4.1 Business Overview
- 10.4.2 Products and Services
10.5 Juventix Regenerative Medical, LLC.
- 10.5.1 Business Overview
- 10.5.2 Products and Services
10.6 Terumo Cardiovascular Systems Corporation
- 10.6.1 Business Overview
- 10.6.2 Financial Snapshot
  - 10.6.2.1 Revenue by Geographic Region
- 10.6.3 Products and Services
10.7 Zimmer Biomet
- 10.7.1 Business Overview
- 10.7.2 Financial Snapshot
  - 10.7.2.1 Net Sales by Geographic
  - 10.7.2.2 Net Sales by Product Category
- 10.7.3 Products and Services
- 10.7.4 Recent Developments
10.8 Isto Biologics
- 10.8.1 Business Overview
- 10.8.2 Products and Services
- 10.8.3 Recent Developments
10.9 APEX Biologix
- 10.9.1 Business Overview
- 10.9.2 Products and Services
- 10.9.3 Recent Developments
10.10 Regen Lab SA
- 10.10.1 Business Overview
- 10.10.2 Products and Services

多血小板血漿市場、規模、シェア、動向、産業分析レポート：タイプ別、用途別、最終用途別、地域別- 市場予測、2024年～2032年

Platelet Rich Plasma Market Size, Share, Trends, Industry Analysis Report: By Type, By Application, By End-Use, and By Region - Market Forecast, 2024 - 2032

PRP市場レポートハイライト

目次

第1章イントロダクション

第2章調査手法

第3章エグゼクティブサマリー

第4章市場の洞察

第5章多血小板血漿（PRP）市場：タイプ別

第6章多血小板血漿（PRP）市場：用途別

第7章多血小板血漿（PRP）市場：最終用途別

第8章多血小板血漿（PRP）市場：地域別

第9章競合情勢

第10章企業プロファイル

List of Tables

List of Figures

PRP Market Report Highlights

PRP Market - Type Outlook (Revenue - USD million, 2019 - 2032)

Platelet Rich Plasma Market - Application Outlook (Revenue - USD million, 2019 - 2032)

Platelet Rich Plasma Market - End-Use (Revenue - USD million, 2019 - 2032)

Platelet Rich Plasma Market - Regional Outlook (Revenue - USD million, 2019 - 2032)

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Insights

5. Platelet Rich Plasma (PRP) Market Assessment by Type

6. Platelet Rich Plasma (PRP) Market Assessment by Application

7. Platelet Rich Plasma (PRP) Market Assessment by End-Use

8. Platelet Rich Plasma (PRP) Market Assessment by Region

9. Competitive Landscape

10. Company Profiles

多血小板血漿市場、規模、シェア、動向、産業分析レポート：タイプ別、用途別、最終用途別、地域別- 市場予測、2024年～2032年

Platelet Rich Plasma Market Size, Share, Trends, Industry Analysis Report: By Type, By Application, By End-Use, and By Region - Market Forecast, 2024 - 2032

PRP市場レポートハイライト

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の洞察

第5章 多血小板血漿（PRP）市場：タイプ別

第6章 多血小板血漿（PRP）市場：用途別

第7章 多血小板血漿（PRP）市場：最終用途別

第8章 多血小板血漿（PRP）市場：地域別

第9章 競合情勢

第10章 企業プロファイル

List of Tables

List of Figures

PRP Market Report Highlights

PRP Market - Type Outlook (Revenue - USD million, 2019 - 2032)

Platelet Rich Plasma Market - Application Outlook (Revenue - USD million, 2019 - 2032)

Platelet Rich Plasma Market - End-Use (Revenue - USD million, 2019 - 2032)

Platelet Rich Plasma Market - Regional Outlook (Revenue - USD million, 2019 - 2032)

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Insights

5. Platelet Rich Plasma (PRP) Market Assessment by Type

6. Platelet Rich Plasma (PRP) Market Assessment by Application

7. Platelet Rich Plasma (PRP) Market Assessment by End-Use

8. Platelet Rich Plasma (PRP) Market Assessment by Region

9. Competitive Landscape

10. Company Profiles

第1章イントロダクション

第2章調査手法

第3章エグゼクティブサマリー

第4章市場の洞察

第5章多血小板血漿（PRP）市場：タイプ別

第6章多血小板血漿（PRP）市場：用途別

第7章多血小板血漿（PRP）市場：最終用途別

第8章多血小板血漿（PRP）市場：地域別

第9章競合情勢

第10章企業プロファイル